How does Pharmafia find six months old babies for Covid jab experiments?

Anyone who has any remnants of humanity inside has asked this question.
One answer is no secret to anyone: poor countries. But that’s not always the case, and this is where it gets darker.

The ethics of deliberately infecting volunteers with Covid-19 to test vaccines are a complicated issue only if you value something more than human life, which is actually common, but not the case here. So I’m not making a secret that everything I know and feel made me conclude long ago that most medical tests that occurred on humans were abominations permitted only by a massive lack of empathy / humanity and usually driven by financial incentives. Everything that followed after that was but a confirmation. Point being: I’m long over that debate, there is absolutely no essential difference between the Bayer labs in Auschwitz and the Pfizer Labs in London (or wherever).
And I know a large slice of society, if not the majority, still has major moral, rational and ethical concerns about this, luckily, and it can’t be that easy to find these kids without leveraging finances on poorest people, and even then…
Proof to that, Moderna has just publicly admitted it has big difficulties in finding 3000 kids, and I hope they never sort it out. So much so that They appealed to all their presstitutes to make a roll call for them.
Funnily, only days after Moderna’s appeal, CBS lies that they were having “more than enough volunteers, so basically these two messages are now still being propagated simultaneously:
“Last fall, the Clinical Research Institute sent out letters to pediatricians’ offices and posted on Facebook looking for volunteers in the 12-year-old to 17-year-old age group. Though the study will run for 13 months, the researchers have more than enough volunteers for this trial.” – CBS


Since you can’t expect anyone involved to be honest and open about it, based on their past and present performance, and they’re not, where to find the answer? There’s about 50 vaccines being trialed right now, some are moving into babies as young as 6 months old, this IS urgent!
If you need another reminder why, go to Forbes and read “The Hideous Truths of Testing Vaccines on Humans”, or watch the videos below.

To get back to the headline question, remember wherever demand forms, a market forms and an industry develops.

A 2017 report in Gizmodo, entitled “How a Company You’ve Never Heard of Sends you Letters about your Medical Condition,” quotes a company called Acurian saying it purchases “public information” and “lifestyle data” to find candidates.

It does not access your doctor’s medical file. Here are some excerpts:

In the summer of 2015, Alexandra Franco got a letter in the mail from a company she had never heard of called AcurianHealth. The letter, addressed to Franco personally, invited her to participate in a study of people with psoriasis, a condition that causes dry, itchy patches on the skin.

Franco did not have psoriasis. But the year before, she remembered, she had searched for information about it online, when a friend was dealing with the condition. And a few months prior to getting the letter, she had also turned to the internet with a question about a skin fungus. It was the sort of browsing anyone might do, on the assumption it was private and anonymous.

Now there was a letter, with her name and home address on it, targeting her as a potential skin-disease patient. Acurian is in the business of recruiting people to take part in clinical trials for drug companies. How had it identified her? She had done nothing that would publicly associate her with having a skin condition.

When she Googled the company, she found lots of people who shared her bewilderment, complaining that they had been contacted by Acurian about their various medical conditions. Particularly troubling was a parent who said her young son had received a letter from Acurian accurately identifying his medical condition and soliciting him for a drug trial—the first piece of mail he’d had addressed to him besides birthday cards from family members.

Acurian has attributed its uncanny insights to powerful guesswork, based on sophisticated analysis of public information and “lifestyle data” purchased from data brokers. What may appear intrusive, by the company’s account, is merely testimony to the power of patterns revealed by big data.

“We are now at a point where, based on your credit-card history, and whether you drive an American automobile and several other lifestyle factors, we can get a very, very close bead on whether or not you have the disease state we’re looking at,” Acurian’s senior vice president of operations told the Wall Street Journal in 2013.

Yet there’s some medical information that Acurian doesn’t have to guess about: The company pays Walgreens, which uses a privacy exemption for research, to send recruitment letters to its pharmacy customers on Acurian’s behalf, based on the medications they’re using. Under this arrangement, Acurian notes that it doesn’t access the medical information directly; the customers’ identities remain private until they respond to the invitations.

And that is not the entire story. An investigation by the Special Projects Desk has found that Acurian may also be pursuing people’s medical information more directly, using the services of a startup that advertises its ability to unmask anonymous website visitors. This could allow it harvest the identities of people seeking information about particular conditions online, before they’ve consented to anything.

A letter sent out to a Walgreens customer in Connecticut on Acurian’s behalf. It invited her to visit a generic sounding website for people with pulmonary disease. At the time, she had a prescription from Walgreens for asthma.
A letter sent out to a Walgreens customer in Connecticut on Acurian’s behalf. It invited her to visit a generic sounding website for people with pulmonary disease. At the time, she had a prescription from Walgreens for asthma.

If you’re suddenly thinking back on all of the things you’ve browsed for online in your life and feeling horrified, you’re not alone.

AcurianHealth has created dozens and dozens of generic sounding websites for the trials they’re recruiting for: www.trialforCOPD.com, www.studiesforyourarthritis.com, and www.kidsdepressionstudy.com are a few examples of the many websites they own. The sites all feature stock images of people in distress, sometimes include AcurianHealth’s logo, and include promises of up to $1,000 for participating, depending on the study.

An example of one of the Acurian sites, www.sleepapneastudies.com
An example of one of the Acurian sites, http://www.sleepapneastudies.com

Out of view, some of these sites include something else: code from a company called NaviStone—which bills itself as a specialist in matching “anonymous website visitors to postal names and addresses.” So if a person is curious about one of those letters from Walgreens, or follows one of Acurian’s online ads, and visits one of Acurian’s generic disease-specific sites, their identity could be discovered and associated with the relevant condition.

NaviStone says it can send personalized mail to anonymous website visitors with a day or two of their visit.
NaviStone says it can send personalized mail to anonymous website visitors with a day or two of their visit.

This tracking function undermines what’s supposedly a formal separation between Walgreens customer data and Acurian’s recruitment. If Walgreens sends out a bunch of letters to customers taking certain medications, and those customers then visit the generic website controlled by Acurian provided in the letter, Acurian can infer its wave of new visitors are taking those medications—and, if NaviStone delivers on its promise to identify visitors, Acurian can see who they are.

Walgreens gives itself permission to use customers’ health information for “research” purposes, which would include clinical trials, in its privacy policy. It’s been working with Acurian since at least 2013, and in 2015, Walgreens announced it was “leveraging” its 100 million customer database to recruit patients directly for five major drug companies.

When asked about its partnership with Acurian, Walgreens spokesperson Scott Goldberg pointed me to a Walgreens FAQ page about clinical trials. It states that Walgreens doesn’t share health information with third parties without permission, but that a third party may “receive your information if you contact the web-site and/or toll-free number in the letter to seek more information about the clinical trial.”

The question is whether users will know that one of Acurian’s websites has received their information—even if they haven’t necessarily agreed to submit it. NaviStone, an Ohio-based business spun out from the marketing firm CohereOne last year, claims to be able to identify between 60 and 70 percent of anonymous visitors to the websites that use its services.

When we contacted the firm last month to ask how it does this, Allen Abbott, NaviStone’s chief operating officer, said by phone that talking about how its technology works is “problematic.”

“A lot of our competitors would love to know how we made it work,” Abbott said. “We have an advantage that we would be silly to reveal.”

We asked whether the company had thought about the privacy implications involved in identifying people visiting a website for sensitive reasons, and whether there were certain customers the company wouldn’t work with.

“Our business is almost entirely e-commerce, helping retailers sell to their customers,” he said. “There was one site that came into our radar that was adult-related material that we decided not to pursue.”

We then described what Acurian does.

“We don’t work with anyone like that,” he said.

We explained that the call was because we’d found NaviStone’s code on AcurianHealth sites.

“It’s possible,” he then said. “We have a lot of customers.”

But Abbott insisted that NaviStone had found a “privacy compliant way” to identify anonymous website visitors—again saying he couldn’t describe it because it was a proprietary technology.

When we analyzed the NaviStone code on Acurian’s sites, we found one way that NaviStone’s technology works: It collects information as soon as it is entered into the text boxes on forms, before the person actually agrees to submit it. When we typed a test email address in the “Join Us” page on Acurian’s site, it was immediately captured and sent to the company’s servers, even if we later chose to close the page without hitting the “Send” button on the form.

In fact, the information was collected before we got to the part of the form that said, “Your privacy is important to us. By selecting this box, you agree to our Privacy Policy and Terms of Use, and agree that we contact you by phone using automated technology or other means using the information you provided above regarding research studies.” – Gizmodo

But that was long ago in terms of technological progress.

However, the methods persist in 2021, an US local tv station reveals that exactly the same scenario occurred in Cincinnati, with the same company at the center of the scandal. Here’s what they’ve just published:

<<Nancy Brashear opened her mail at her Campbell County, Kentucky, home to find an offer to earn money if she joined a COVID-19 vaccine test.

“I got a letter from Acurian Health looking for volunteers for a COVID vaccine study, promising up to $1,200 if you participate or volunteer,” she said.

It looked promising, but Brashear said she started to wonder how they knew she would be a good candidate for a vaccine trial. Did someone with a hospital, doctor’s office or pharmacy sell her health information?

“How do they get my information?” Brashear said. “That really bothers me.”

We called and emailed Acurian Health to find out how they got her name, but did not hear back.

Company is a data firm, not a testing center

Acurian is a legitimate company, according to the Better Business Bureau, and states it is a data firm that connects people with medical trials.

It does not do the actual testing.

“Where did they get this information?” Brashear asked. “HIPPA laws make your history private.”

The Protect Patients Blog has an in-depth article of how Acurian learns if you are a good candidate for a medical trial.

But Brashear found that if you decide to apply, you will then have to give much more medical information to see if you actually qualify. There is no guarantee you will be accepted for a trial, and no guarantee you will earn anything close to $1,200.

“If you go on the website, you have to go through steps to do that, so they are looking for information,” she said.

In the end, she said thanks, but no thanks, wondering if she would be sharing too much medical and personal information with a company she knew little about.

If you want to sign up for a COVID-19 trial, the NIH, National Institutes of Health, is a government site that lists all the authorized vaccine trials going on.

Many of them will pay money, typically a few hundred dollars. However, they may not cover treatment for any side effects.

So be sure to read all the fine print, so you don’t waste your money.>> – WCPO

Also let’s recall our October 2020 article: CONTACT-TRACING DATA HARVESTED FROM PUBS AND RESTAURANTS BEING SOLD ON

I don’t know about you, but what I’ve learned so far is:

  1. Pharmafia still does whatever it takes to get what it wants, even primitive hacking as described above.
  2. These methods are still too primitive for the biggest actors in Pharmafia who are well into artificial intelligence and cutting edge technologies

So what are these top cats doing then?
I’ve consulted some of my insider sources, put it together with my own digs and, as per usual with these creatures, the most obvious suspicions are also true.

If you’ve been around, you should be aware by now of three tendencies that are one, actually:


1. Big Tech and Big Pharma are merging

2. Healthcare and Big Data are merging

They’re not only after health data, don’t worry, all data helps a sale


3. The above are merging with media and the elected government

What are Google and Facebook selling, in fact?
Your data.
What for?
So you can be best manipulated by different interests, with custom-design ads and policies.

Oracle’s National Electronic Health Records Cloud dates back to the beginnings of the COVID-19 pandemic. In March 2020, a couple of weeks after letting President Trump use his estate near Palm Springs for a $100,000-a-plate golfing fundraiser, Ellison placed a call to the White House. According to a Forbes cover story on Ellison, he “asked Trump if a clearinghouse existed for real-time data about treatment efficacies and outcomes.”

Within a week after the president asked “how much?” and Ellison said, “for free,” the tech titan had brought together a team of Oracle engineers “to build a database and website registering coronavirus cases” and work with the National Institutes of Health (NIH), U.S. Food and Drug Administration (FDA) and other agencies.

The first public acknowledgment of Oracle’s progress came on July 3, 2020, when the NIH’s National Institute for Allergies and Infectious Diseases (NIAID), overseen by Dr. Anthony Fauci, launched the COVID-19 Prevention Trials Network (COVPN), aimed at enrolling thousands of volunteers in large-scale trials for a variety of investigational vaccines and monoclonal antibodies.

Fauci achieved this by merging four existing networks, all researching HIV/AIDS, something they would continue to do. “The network is expected to operate more than 100 clinical trial sites across the United States and internationally,” according to the NIAID press release which also stated “the COVPN website features a customized data collection platform, which Oracle (Redwood Shores, CA) built and donated, to securely identify potential trial participants.”

In August, a paper published by the Johns Hopkins Center for Health Security proposed that the “passive reporting” systems managed by the CDC and FDA ought to be revamped to forge “an active safety surveillance system directed by the CDC that monitors all [COVID-19] vaccine recipients — perhaps by short message service or other electronic mechanisms.”

By September, Operation Warp Speed director Moncef Slaoui was telling the periodical Science: “We’re working super hard on a very active pharmacovigilance system, to make sure that when the vaccines are introduced that we’ll absolutely continue to assess their safety.

In October, Slaoui told the New York Times: “The FDA is proposing that at least 50% of the individuals in the study population have at least two months of follow-up on safety before the vaccines are approved. And secondly, we are working really hard with the FDA and the CDC to make sure we have a very active pharmacovigilance surveillance system to allow us to continue to assess the safety of the vaccines as they are being used in the high risk population.”

And the Wall Street Journal reported in a profile of Slaoui that he’d said “tracking systems will have to be ‘incredibly precise’ to ensure that patients each get two doses of the same vaccine and to monitor them for adverse health effects. Operation Warp Speed has selected the medical-distribution company McKesson and cloud operators Google and Oracle to collect and track vaccine data.”

“This marked the first time that Oracle’s role was revealed to have expanded to include Operation Warp Speed.

Oracle Chairman Ellison’s lucrative government arrangements trace back to the data software pioneer’s origins. In 1975, then in his early thirties, Ellison worked on a project for the electronics company Ampex in the Bay area, building a large terabit memory system for the CIA.

Ellison revealed in 2014 that the CIA not only became his firm’s first customer for a “relational database” two years later, but that he adopted the name from a CIA project called Oracle. “The news about our hot little database traveled around the intelligence community pretty quickly,” Ellison was quoted as saying in the 2003 book, “Softwar.” “In a little over six months’ time we had won several deals — the CIA, Navy Intelligence, Air Force Intelligence and the NSA [National Security Agency].” – Technocracy News

From this industry’s perspective, you enrolling KFC’s Fidelity Club or a vaccine trial is the same technical challenge. One that they keep winning lately.

Remember when the sister of YouTube’s CEO and former wife of Google’s founder Sergey Brin, still a business partner, set up a DNA testing company and then sold the data for $300 million to pharma giant genocidal company GSK?

Source

Oh, it’s all about science and health, sure, but what science and whose health?
Because anyone who’s been in touch with reality lately knows a few more things:
– Pharmafia invests much more in the science of marketing than in medical sciences
– That data often comes from marketing experts such as Google and Facebook
– Marketing and propaganda sell and persuade much more efficiently than science when it comes to large masses of people. Or all of them. It’s way easier and cheaper to manipulate the low-IQ majority than to heal it. Especially with these tools Big Tech brought aboard.

What keeps them from finding and manipulating the feeble minds they need for these new atrocities they call “vaccines human trials” and, in fact, are neither vaccines or human, just deranged human abuse experimentation?
From what I’ve found out so far, the answer is: nothing.
Everything you type on your computer is collected and can be processed to obtain a method to target and determine people to subject their kids to this. It’s probably much easier to sell than some of their other products. This is already a massive industry that often breaks ethical and even legal barriers.

Source: The Guardian


What, you’ve never thought Cambridge Analytica can work for Pharmafia too?
Well then remember we’ve passed that, Facebook, Amazon, Microsoft (recording my typing right now) and Alphabet (Google) are not distinguishable from Pharmafia at all. The concept that they wouldn’t take any and all advantage of their new powers and domination is comically delirious.
Moderna must be running out of money or love if Google won’t send them a mere 3000 kids, no joke.

We are funded solely by our most generous readers and we want to keep this way. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

Comments are closed.